Correlation Between Binance Coin and Inhibikase Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Binance Coin and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Binance Coin and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Binance Coin and Inhibikase Therapeutics, you can compare the effects of market volatilities on Binance Coin and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Binance Coin with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Binance Coin and Inhibikase Therapeutics.

Diversification Opportunities for Binance Coin and Inhibikase Therapeutics

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Binance and Inhibikase is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Binance Coin and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Binance Coin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Binance Coin are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Binance Coin i.e., Binance Coin and Inhibikase Therapeutics go up and down completely randomly.

Pair Corralation between Binance Coin and Inhibikase Therapeutics

Assuming the 90 days trading horizon Binance Coin is expected to generate 0.2 times more return on investment than Inhibikase Therapeutics. However, Binance Coin is 5.04 times less risky than Inhibikase Therapeutics. It trades about -0.16 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about -0.32 per unit of risk. If you would invest  71,453  in Binance Coin on November 2, 2024 and sell it today you would lose (3,637) from holding Binance Coin or give up 5.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy90.48%
ValuesDaily Returns

Binance Coin  vs.  Inhibikase Therapeutics

 Performance 
       Timeline  
Binance Coin 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Binance Coin are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental drivers, Binance Coin exhibited solid returns over the last few months and may actually be approaching a breakup point.
Inhibikase Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibikase Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Binance Coin and Inhibikase Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Binance Coin and Inhibikase Therapeutics

The main advantage of trading using opposite Binance Coin and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Binance Coin position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.
The idea behind Binance Coin and Inhibikase Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities